(Q52049961)

20 April 2018

title

Effects of M2 antagonists on in vivo hippocampal acetylcholine levels. (English)

1 reference

20 April 2018

author name string

Stillman MJ

1

1 reference

20 April 2018

Shukitt-Hale B

2

1 reference

20 April 2018

Galli RL

3

1 reference

20 April 2018

Levy A

4

1 reference

20 April 2018

Lieberman HR

5

1 reference

20 April 2018

publication date

1 January 1996

1 reference

20 April 2018

published in

Brain Research Bulletin

1 reference

20 April 2018

volume

41

1 reference

20 April 2018

page(s)

221-226

1 reference

20 April 2018

issue

4

1 reference

20 April 2018

Cholinergic markers in aged cognitively impaired Long-Evans rats

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900180-3

7 January 2021

The cholinergic hypothesis of geriatric memory dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900180-3

7 January 2021

Effects of muscarinic receptor agonists and antagonists on rat brain serotonergic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900180-3

7 January 2021

Reversal of age-related cognitive impairments by an M1 cholinergic agonist, AF102B.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900180-3

7 January 2021

An in vivo pharmacological study on muscarinic receptor subtypes regulating cholinergic neurotransmission in rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900180-3

7 January 2021

Measurement of acetylcholine release in freely moving rats by means of automated intracerebral dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900180-3

7 January 2021

Cholinergic activity in the rat hippocampus, cortex and striatum correlates with locomotor activity: an in vivo microdialysis study.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900180-3

7 January 2021

Therapeutic potential of CNS-active M2 antagonists: novel structures and pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900180-3

7 January 2021

(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3') quinuclidine (AF102B): a new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900180-3

7 January 2021

Biochemical and behavioral evidence for muscarinic autoreceptors in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900180-3

7 January 2021

Effects of choline administration on in vivo release and biosynthesis of acetylcholine in the rat striatum as studied by in vivo brain microdialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900180-3

7 January 2021

Binding sites for [3H]AF-DX 116 and effect of AF-DX 116 on endogenous acetylcholine release from rat brain slices

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900180-3

7 January 2021

The Biochemistry of Memory: A New and Specific Hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900180-3

7 January 2021

Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900180-3

7 January 2021

Release of acetylcholine and noradrenaline from the cholinergic and adrenergic afferents in rat hippocampal CA1, CA3 and dentate gyrus regions.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900180-3

7 January 2021

Muscarinic M1 and M2 receptors mediate depolarization and presynaptic inhibition in guinea-pig enteric nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900180-3

7 January 2021

Post-training injection of the acetylcholine M2 receptor antagonist AF-DX 116 improves memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900180-3

7 January 2021

Muscarinic and nicotinic modulation of cortical acetylcholine release monitored by in vivo microdialysis in freely moving adult rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900180-3

7 January 2021

Facilitation of acetylcholine release and cognitive performance by an M(2)-muscarinic receptor antagonist in aged memory-impaired.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900180-3

7 January 2021

Nimodipine prevents the in vivo decrease in hippocampal extracellular acetylcholine produced by hypobaric hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900180-3

7 January 2021

Elevation of hippocampal extracellular acetylcholine levels by methoctramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900180-3

7 January 2021

Oral physostigmine and lecithin improve memory in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900180-3

7 January 2021

Presynaptic effects of methoctramine on release of acetylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900180-3

7 January 2021

Heterogeneity of presynaptic muscarinic receptors involved in modulation of transmitter release

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2896%2900180-3

7 January 2021

10.1016/S0361-9230(96)00180-3

Identifiers

DOI

1 reference

20 April 2018

release_qdamq72hdnfovo32bnqp3whfu4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qdamq72hdnfovo32bnqp3whfu4

24 November 2022

mapped directly with Wikidata item

PubMed ID

8924031

1 reference

20 April 2018